CR10467A - Profarmacos de penem - Google Patents

Profarmacos de penem

Info

Publication number
CR10467A
CR10467A CR10467A CR10467A CR10467A CR 10467 A CR10467 A CR 10467A CR 10467 A CR10467 A CR 10467A CR 10467 A CR10467 A CR 10467A CR 10467 A CR10467 A CR 10467A
Authority
CR
Costa Rica
Prior art keywords
profarms
penem
sulopenem
prodrugs
solvates
Prior art date
Application number
CR10467A
Other languages
English (en)
Inventor
Katherine Elizabeth Brighty
Anthony Marfat
Dale Gordon Mcleod
John Paul O'donnell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CR10467A publication Critical patent/CR10467A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Profarmacos de sulopenem con biodisponibilidad por via oral, por ejemplo, y sus solvatos e hidratos, su preparacion, su formulacion y su uso para tratar y prevenir la infeccion en mamiferos tales como seres humanos. Este resumen no limita la invencion.
CR10467A 2006-06-28 2008-11-27 Profarmacos de penem CR10467A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13

Publications (1)

Publication Number Publication Date
CR10467A true CR10467A (es) 2009-01-19

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10467A CR10467A (es) 2006-06-28 2008-11-27 Profarmacos de penem

Country Status (28)

Country Link
US (2) US7795243B2 (es)
EP (1) EP2044085B1 (es)
JP (2) JP4397435B2 (es)
KR (1) KR101060448B1 (es)
AP (1) AP2008004705A0 (es)
AR (1) AR061646A1 (es)
AT (1) ATE493419T1 (es)
AU (1) AU2007263519B2 (es)
BR (1) BRPI0712740A2 (es)
CA (1) CA2655485C (es)
CL (1) CL2007001910A1 (es)
CR (1) CR10467A (es)
DE (1) DE602007011622D1 (es)
DK (1) DK2044085T3 (es)
EA (1) EA200870584A1 (es)
EC (1) ECSP088947A (es)
GT (1) GT200700050A (es)
IL (1) IL195383A0 (es)
MA (1) MA30568B1 (es)
MX (1) MX2009000116A (es)
NL (1) NL2000715C2 (es)
NO (1) NO20090392L (es)
PE (1) PE20080940A1 (es)
SV (1) SV2008003139A (es)
TN (1) TNSN08537A1 (es)
TW (1) TW200816999A (es)
UY (1) UY30439A1 (es)
WO (1) WO2008001212A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (en) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. O-alkylated pi-3 kinase inhibitor prodrug combination
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
CN102471248B (zh) * 2009-08-10 2015-01-07 Bhi有限合伙公司 用于递送1,3-丙二磺酸的方法、化合物和组合物
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
CN112739330A (zh) 2019-02-13 2021-04-30 伊泰伦治疗国际有限公司 β-内酰胺化合物和丙磺舒的组合及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) * 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
WO1988008845A1 (en) * 1987-05-11 1988-11-17 Pfizer Inc. Diastereomeric 5r,6s-6-(1r-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
GB8713515D0 (en) * 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
DE69130363T2 (de) * 1990-08-20 1999-04-22 Suntory Limited, Osaka Antibakterielle penemverbindungen
ATE186537T1 (de) 1990-08-20 1999-11-15 Suntory Ltd Antibakterielle penem-ester derivate
WO2004067532A1 (ja) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. 新規カルバペネム誘導体
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080015494A1 (en) * 2006-07-11 2008-01-17 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
JP5152527B2 (ja) 2013-02-27
HK1134928A1 (en) 2010-05-20
IL195383A0 (en) 2009-08-03
MA30568B1 (fr) 2009-07-01
WO2008001212A3 (en) 2008-03-20
US7795243B2 (en) 2010-09-14
MX2009000116A (es) 2009-01-23
AU2007263519B2 (en) 2011-05-19
AR061646A1 (es) 2008-09-10
KR101060448B1 (ko) 2011-08-29
AU2007263519A1 (en) 2008-01-03
TW200816999A (en) 2008-04-16
BRPI0712740A2 (pt) 2012-06-05
CL2007001910A1 (es) 2008-01-11
CA2655485A1 (en) 2008-01-03
US7795244B2 (en) 2010-09-14
EP2044085B1 (en) 2010-12-29
ATE493419T1 (de) 2011-01-15
TNSN08537A1 (fr) 2010-04-14
KR20090015147A (ko) 2009-02-11
PE20080940A1 (es) 2008-07-09
AP2008004705A0 (en) 2008-12-31
NL2000715C2 (nl) 2008-03-11
EA200870584A1 (ru) 2009-06-30
JP4397435B2 (ja) 2010-01-13
US20090042853A1 (en) 2009-02-12
UY30439A1 (es) 2008-01-31
CA2655485C (en) 2011-08-02
DK2044085T3 (da) 2011-03-07
NO20090392L (no) 2009-01-27
WO2008001212A2 (en) 2008-01-03
US20080009474A1 (en) 2008-01-10
JP2010013468A (ja) 2010-01-21
GT200700050A (es) 2008-02-01
EP2044085A2 (en) 2009-04-08
SV2008003139A (es) 2010-01-12
NL2000715A1 (nl) 2008-01-02
JP2009542616A (ja) 2009-12-03
ECSP088947A (es) 2009-01-30
DE602007011622D1 (en) 2011-02-10

Similar Documents

Publication Publication Date Title
UY32327A (es) Antagonistas de receptores de ácido lisofosfatídico
HN2008001464A (es) Formulaciones para administrcion parenteral de compuestos y sus usos
MX388468B (es) Compuestos multicíclicos y métodos de uso de los mismos.
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
ECSP088947A (es) Profarmacos de penem
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
CY1118062T1 (el) Συνθεσεις για την αντιμετωπιση της ναυτιας και του εμετου κεντρικης προελευσης
NI200900093A (es) Compuestos que modulan la actividad de c-fms y/o c-kit y uso de los mismos.
CL2008001879A1 (es) Compuestos derivados de isaxolinas-naftalen-carboamida; y el uso de los compuestos en el control de plagas de invertebrados en animales.
UY33616A (es) Compuestos con estructura de imidazotriazinona
PA8720801A1 (es) Nuevas combinaciones terapeuticas para el tratamiento de la depresion
HN2008000178A (es) Compuestos triciclicos, composiciones y procedimientos
EA201170832A1 (ru) Пуриновые соединения
ECSP109923A (es) Bromhidrato de bupropion y aplicaciones terapéuticas
CL2011001427A1 (es) Compuestos derivados de 4-azetidinil-1-heteroaril-ciclohexanol; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como epoc, aterosclerosis, artritis reumatoide, entre otras.
BRPI0814772A2 (pt) Indazóis substituídos por 5-piridinona
CR20130306A (es) Compuestos y su uso
BR112015013675A2 (pt) composições compreendendo vortioxetina e donepezil
HN2003000080A (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
CL2011002617A1 (es) Compuestos derivados de arilsulfonamidas 2,5-disustituidas, moduladores del receptor ccr3; composicion farmaceutica que los comprende; y uso del compuesto o de la composicion para prevenir y/o tratar un trastorno inflamatorio o inmunoregulador tal como asma, rinitis, vih, enfermedad de alzheimer, entre otros.
GT200600117A (es) Nuevos compuestos farmaceuticos
TN2009000510A1 (en) Extended release formulation of nevirapine
MX2010008852A (es) Formulaciones de flibanserina.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)